Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02515045 · ClinicalTrials.gov registry record · Phase 4
Dropless vs. Standard Drops Contralateral Eye Study
A Phase 4 study of Cataract, sponsored by Carolina Eyecare Physicians.
- Completed
- Registry status
- Phase 4
- Development phase
- 59
- Enrollment target
- 4
- Study locations
NCT02515045: Completed Phase 4 study of Cataract, sponsored by Carolina Eyecare Physicians.
NCT02515045 is a Phase 4 study of Cataract that has completed, run by Carolina Eyecare Physicians. The registered enrollment target is 59 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (74% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02515045, a Phase 4 study of Cataract, has completed, sponsored by Carolina Eyecare Physicians.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 59 participants
- Enrollment target
- 4
- Study locations
Study Summary
To compare the use of an injectable compound containing an antibiotic and an anti-inflammatory at time of cataract surgery to standard of care that is the use 3 different topical medications to prevent inflammation and infection after routine cataract surgery.
Primary Outcome
Macula is the area in the retina that is responsible for the best central vision. Changes in its thickness may occur after cataract surgery due to the normal inflammatory process that occurs postoperatively but it returns to preoperative values unless there is an underlying disease.
Conditions Studied
Interventions
- DRUG TriMoxiVanc
- DRUG Moxifloxacin HCl 0.5%
- DRUG Ilevro
- DRUG Prednisolone acetate 1%
Study Locations (4)
Minnesota
- Minnesota Eye Consultants, P.A. - Bloomington
- Associated Eye Care - Stillwater
New York
- Ophthalmic Consultants of Long Island - Garden City
South Carolina
- Carolina Eyecare Physicians, LLC - Mt. Pleasant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-03 |
| Phase | Phase 4 |
What the finished NCT02515045 record still lists
NCT02515045 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Cataract appearing as the primary indexed condition, and to 4 interventions - of which TriMoxiVanc is the first listed.
NCT02515045 reports a single indexed study location in Minnesota, New York, South Carolina.
Frequently Asked Questions
What is clinical trial NCT02515045 about?
NCT02515045 is a clinical study titled "Dropless vs. Standard Drops Contralateral Eye Study". To compare the use of an injectable compound containing an antibiotic and an anti-inflammatory at time of cataract surgery to standard of care that is the use 3 different topical medications to prevent inflammation and infection after routine cataract surgery.
What is the current status of trial NCT02515045?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 59 participants. The study started on 2015-01. Estimated completion is 2016-03.
What conditions does trial NCT02515045 study?
This clinical trial studies the following conditions: Cataract.
What interventions are being tested in trial NCT02515045?
The interventions under investigation include: TriMoxiVanc (DRUG), Moxifloxacin HCl 0.5% (DRUG), Ilevro (DRUG), Prednisolone acetate 1% (DRUG).
Who is sponsoring clinical trial NCT02515045?
This trial is sponsored by Carolina Eyecare Physicians, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02515045 being conducted?
This trial has 4 study locations across Minnesota, New York, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02515045's enrollment target sits among peer trials
59 55th of 83 higher than 29 of 83 other Cataract trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
RECRUITING · Phase 4
-
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
RECRUITING · Phase 4
-
Evaluation of a Monofocal Intraocular Lens
RECRUITING · Phase 4
-
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
RECRUITING · Phase 4
-
Odyssey Evaluation in Post LASIK Patients
RECRUITING · Phase 4
-
Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia